These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10774745)

  • 1. Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines.
    Choi CH; Kim HS; Kweon OS; Lee TB; You HJ; Rha HS; Jeong JH; Lim DY; Min YD; Kim MS; Chung MH
    Mol Cells; 2000 Feb; 10(1):38-46. PubMed ID: 10774745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
    Kim HS; Lee TB; Choi CH
    Biochem Biophys Res Commun; 2001 Feb; 281(1):109-14. PubMed ID: 11178967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of daunorubicin-resistant AML-2 sublines.
    Choi CH; Ling V
    Mol Cells; 1997 Apr; 7(2):170-7. PubMed ID: 9163728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
    Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
    Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates.
    Messingerova L; Imrichova D; Kavcova H; Turakova K; Breier A; Sulova Z
    Toxicol In Vitro; 2015 Oct; 29(7):1405-15. PubMed ID: 26009263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
    Ishii M; Iwahana M; Mitsui I; Minami M; Imagawa S; Tohgo A; Ejima A
    Anticancer Drugs; 2000 Jun; 11(5):353-62. PubMed ID: 10912951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines.
    Whelan RD; Hosking LK; Townsend AJ; Cowan KH; Hill BT
    Cancer Commun; 1989; 1(6):359-65. PubMed ID: 2702041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
    Kim HS; Min YD; Choi CH
    Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6.
    Sato M; Sasaki M; Hojo H
    Arch Biochem Biophys; 1995 Feb; 316(2):738-44. PubMed ID: 7532385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin.
    Osmak M; Eljuga D
    Res Exp Med (Berl); 1993; 193(6):389-96. PubMed ID: 8122044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
    Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
    Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.
    Siegsmund MJ; Marx C; Seemann O; Schummer B; Steidler A; Toktomambetova L; Köhrmann KU; Rassweiler J; Alken P
    Urol Res; 1999 Jun; 27(3):157-63. PubMed ID: 10422815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of anti-tumour drug responses and mechanisms of resistance in a series of independently-derived VP-16-resistant human tumour cell lines.
    Lock RB; Hill BT
    Int J Cancer; 1988 Sep; 42(3):373-81. PubMed ID: 3417366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH; Kang G; Min YD
    Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Antioxidant Enzymes and Content of Reduced Glutathione in Cells of Drug-Resistant Murine Leukemia P388 Strains.
    Balakina AA; Raevskaya TA; Pavlov VS; Mumyatova VA; Goncharova SA; Terent'ev AA
    Bull Exp Biol Med; 2019 Jul; 167(3):339-342. PubMed ID: 31346869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.